Results 21 to 30 of about 53,541 (251)
Scientific Reports, 2018 Peritoneal adhesions develop after abdominal surgery, trauma or intraperitoneal infections, and have important consequences. The deposition of peritoneal fibrin is a common pathophysiological pathway for the formation of adhesions.
Cheng-Chung Fang +4 more
doaj +1 more source
Polymers in the prevention of peritoneal adhesions [PDF]
European Journal of Pharmaceutics and Biopharmaceutics, 2008 Peritoneal adhesions are serious complications of surgery, and can result in pain, infertility, and potentially lethal bowel obstruction. Pharmacotherapy and barrier devices have reduced adhesion formation to varying degrees in preclinical studies or clinical trials; however, complete prevention of adhesions remains to be accomplished.
Yoon, Yeo, Daniel S, Kohane
openaire +2 more sources
Journal of Experimental & Clinical Cancer Research, 2010 Background Peritoneal dissemination is one of the main causes of death in gastric cancer patients. Transforming growth factor-beta1 (TGF-β1), one of the most potent fibrotic stimuli for mesothelial cells, may play a key role in this processing.
Ma Xiao-Yang +8 more
doaj +1 more source
Rosmarinic acid prevents post-operative abdominal adhesions in a rat model
Scientific Reports, 2022 This study aims to determine the effects of rosmarinic acid which involved the mechanisms to decrease the postoperative peritoneal adhesion formation in rats. Various incisions and removing a 1 × 1 cm piece of peritoneum was used to induce the peritoneal
Ali Kakanezhadi +5 more
doaj +1 more source
The effect of atorvastatin topical solution on preventing peritoneal adhesion in rats [PDF]
Journal of Kerman University of Medical SciencesBackground: Peritoneal adhesion is a critical postsurgical complication in abdominal and pelvic surgeries. Due to their anti-inflammatory and fibrinolytic properties, statins are assumed to reduce peritoneal adhesions effectively.
Ramin Hasani Yazdi +7 more
doaj +1 more source
The tripeptide feG inhibits leukocyte adhesion
Journal of Inflammation, 2008 Background The tripeptide feG (D-Phe-D-Glu-Gly) is a potent anti-inflammatory peptide that reduces the severity of type I immediate hypersensitivity reactions, and inhibits neutrophil chemotaxis and adhesion to tissues. feG also reduces the expression of
Davison Joseph S +2 more
doaj +1 more source